The word “psychedelic” often conjures images of tie-dye and VW buses, but a Canadian mental health company is seeking to change that perception by advancing new treatments and research into psychedelic therapy. Their goal is to bring this type of healing into mainstream clinical practice.
Psychedelic-assisted psychotherapy, or P-AT, involves the use of consciousness-altering drugs like psilocybin and MDMA in combination with traditional talk therapy. This form of treatment has shown promise in reducing symptoms of conditions such as PTSD and depression. In fact, it has been found to be effective in treatment-resistant depression and anxiety related to serious medical illness.
Professional Psychedelic Therapy Canada psychedelics can cause a wide range of psychological effects, they are generally considered to be safe when administered in controlled settings by qualified practitioners. However, some people may be at higher risk for negative side effects, such as triggering psychosis or manic episodes. This is why it’s important to talk with your therapist about any family history of these disorders and ask for testing kits that can detect the presence of harmful additives or contaminants.
Canadian Magic Mushroom Delivery: Where to Shop Online
Although psilocybin and MDMA are legal in Canada for scientific research and medical use, they remain illegal to possess or transport for recreational purposes. As a result, psilocybin-assisted therapy must be carried out in a facility that is licensed to do so. In 2022, Alberta became the first province to provide regulatory guidelines for psilocybin-assisted psychotherapy. While this is a promising step, it’s important to keep in mind that P-AT is still not available everywhere.